FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080681 [Registered on: 17/02/2025] Trial Registered Prospectively
Last Modified On: 08/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study to Compare Effects Of Isobaric Levobupivacaine and Isobaric Ropivacaine In Labor Analgesia 
Scientific Title of Study   Study to Compare Effects Of Isobaric Injection Levobupivacaine and Isobaric Injection Ropivacaine In Labor Analgesia 
Trial Acronym  LECRA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anil Kumar 
Designation  Assistant Professor 
Affiliation  Government Medical College Jalaun 
Address  Department of Anesthesia Government Medical College, Jalaun(Orai) 285001 First Floor Room Number 2

Jalaun
UTTAR PRADESH
285001
India 
Phone  9454224498  
Fax    
Email  dranilkumarucr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunit Kumar 
Designation  Associate Professor 
Affiliation  Government Medical College Jalaun 
Address  Department of Anesthesia Government Medical College, Jalaun(Orai) 285001 First Floor Room Number 2

Jalaun
UTTAR PRADESH
285001
India 
Phone  9532456809  
Fax    
Email  sunit.sachan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anil Kumar 
Designation  Assistant Professor 
Affiliation  Government Medical College , Jalaun 
Address  Department of Anesthesia Main Block ,First Floor, Room number 2 Government Medical College , Jalaun (Orai)

Jalaun
UTTAR PRADESH
285001
India 
Phone  9454224498  
Fax    
Email  dranilkumarucr@gmail.com  
 
Source of Monetary or Material Support  
Government Medical College , Jalaun(Orai) 285001 Uttar Pradesh, India 
 
Primary Sponsor  
Name  Government Medical College Jalaun Orai 
Address  Department Of Anesthesia, Government Medical College, First Floor Room number 2 Jalaun(Orai) 285001, Uttar Pradesh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anil Kumar  Rajkiya Medical college , Orai, Jalaun  Hospital Block, O.T. Complex Government Medical College, Jalaun
Jalaun
UTTAR PRADESH 
9454224498

dranilkumarucr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
government Medical college Jalaun Institute Ethical Committee ( Human Studies)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery, (2) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  INJECTION LEVOBUPIVACAINE  INJECTION LEVOBUPIVACAINE 25 mg loading dose and then 10mg per hour till delivery 
Comparator Agent  INJECTION ROPIVACAINE  INJECTION ROPIVACAINE 37.5 mg loading dose then 15 mg per hour till delivery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  all pregnant females of age 18 years TO 40 years 
 
ExclusionCriteria 
Details  1 Uncontrolled diabetes and hypertension.
2 Chronic renal diseases
3 Chronic Anemia
4 I.H.D. or any other cardiac condition.
5 Peripheral vascular disease 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Maternal blood pressure
pain relief
preservation of lower limb motor power
duration and progress of labor
fetal outcome were evaluated  
BASELINE, 6 HOURS AND 12 HOURS  
 
Secondary Outcome  
Outcome  TimePoints 
hemodynamic stability  12 HOURS AND 24 HOURS AFTER SURGERY 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dranilkumarucr@gmail.com].

  6. For how long will this data be available start date provided 27-03-2025 and end date provided 28-01-2026?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

This  study was taken to  compare the effects on the labor and neonates of segmental epidural analgesia conducted  with Levobupivacaine and  Ropivacaine with fentanyl as opioid as adjuvant . 90 parturients were included in the study. They were randomly divided in two groups. patients received levobupivacaine and ropivacaine ,  Epinephrine was not added to local anesthetics. The first dose was 25 mg of levobupivacaine  0.25% (10 ml) and 10 micro gram of inj. Fentanyl and 37.5 mg for Ropivacaine 0.375% (10 ml). Reinjections occurred every 60 min for levobupivacaine ( 10 mg)  and ever 60 min for Ropivacaine (15  mg).. Umbilical cord blood was drawn for pH determination.

Patients in both the groups were compared for Maternal  blood pressure, pain relief, preservation of lower limb motor power, duration and progress of labour, and foetal outcome were evaluated , and need for emergency caesarean section is considered


 
Close